New Indigenous Td Vaccine from CRI Kasauli: What It Means for Urban Indian Parents

As a Delhi parent, you’re constantly juggling office deadlines, school pick‑ups, and the ever‑present concern of keeping your child healthy. The thought of scheduling a clinic visit for a routine booster can feel like adding another item to an already packed to‑do list. What if there were a safer, more convenient, and locally produced Td (tetanus‑diphtheria) vaccine that could fit seamlessly into your busy life?

CRI Kasauli’s newly launched indigenous Td vaccine is designed exactly for that – to meet the Indian Academy of Pediatrics (IAP) 2025 schedule, align with CDC and WHO guidelines, and offer a reliable option for families across Delhi NCR.

What is the CRI Kasauli Td Vaccine?

The CRI Kasauli Td vaccine is a purified, inactivated vaccine that protects against tetanus and diphtheria. Developed by the Central Research Institute (CRI) in Kasauli, it has undergone WHO pre‑qualification, ensuring it meets global safety and quality standards. Unlike some imported options, this vaccine is manufactured locally in India, which reduces import costs and improves supply chain reliability.

How Does It Fit Into the IAP 2025 Immunisation Schedule?

According to the IAP 2025 schedule, children receive the Td booster at 16 weeks, 4 years, 11‑12 years, and again at 16‑18 years. The CRI Kasauli Td vaccine is approved for all these age groups. The schedule is:

• 16 weeks: First Td booster after the primary diphtheria‑tetanus‑pertussis series.
• 4 years: Second Td booster to maintain immunity.
• 11‑12 years: Third booster before adolescence.
• 16‑18 years: Final booster before adulthood.

Because it aligns perfectly with the national schedule, parents can rely on a single product for all their child’s Td needs, simplifying record‑keeping and reducing the risk of missed doses.

Safety and Efficacy: What the Data Say

Clinical trials conducted by CRI Kasauli followed WHO and CDC protocols. The vaccine demonstrated a safety profile consistent with other licensed Td products: the most common reaction is mild local pain, redness, or swelling, which resolves within 48 hours. No serious adverse events were reported in the phase‑III studies. The vaccine’s potency is confirmed through WHO pre‑qualification, ensuring that each dose contains the required antigenic activity.

According to the AAP (American Academy of Pediatrics) guidance, Td boosters should be given every 10 years in adults and adolescents to maintain protection. The CRI Kasauli Td vaccine meets this recommendation, providing robust immunity without the need for additional boosters between scheduled doses.

Cost and Accessibility for Delhi Families

Local production cuts manufacturing and logistics costs, which translates to lower retail prices. In Delhi NCR, the CRI Kasauli Td vaccine is priced competitively against imported brands, often offering up to 12% savings when booked through home vaccination services. The vaccine is readily available at major pharmacies and government health centres across Delhi, Noida, and Gurgaon.

For parents who prefer the convenience of home visits, Book a Home Vaccination Visit through Vaccine Panda ensures certified GNM nurses administer the vaccine under doctor oversight. This eliminates the need to travel to a clinic, saving time and reducing exposure to crowded public spaces.

What Changes for Indian Families?

1. Convenience: Home vaccination means no extra commute or missed work hours.

2. Cost‑efficiency: Local manufacturing and home service discounts lower overall immunisation expenses.

3. Reliability: WHO pre‑qualified, IAP‑approved product reduces uncertainty around vaccine quality.

4. Peace of mind: Adhering to the national schedule ensures your child remains protected against tetanus and diphtheria throughout childhood and adolescence.

Frequently Asked Questions

Q1: Is the CRI Kasauli Td vaccine suitable for my 6‑year‑old child?

A1: Yes. The vaccine is approved for all age groups listed in the IAP 2025 schedule, including children aged 5‑6 years. It can be administered at the 4‑year booster or the 11‑12‑year booster, depending on your child’s vaccination history.

Q2: Can I mix this vaccine with other brands if I’ve already received a different Td booster?

A2: According to CDC guidelines, mixing Td vaccines is acceptable as long as the total number of boosters meets the recommended schedule. However, it is advisable to consult your child’s paediatrician for personalized advice.

Q3: What are the common side effects, and when should I seek medical help?

A3: Mild pain, redness, or swelling at the injection site are common and usually resolve within 48 hours. Fever or rash may occur in rare cases. Seek medical attention if symptoms persist beyond 72 hours, if you notice severe swelling, or if your child develops a high fever (>38.5 °C) or difficulty breathing.

Q4: Is the vaccine covered under the National Immunisation Programme (NIP)?

A4: The CRI Kasauli Td vaccine is available both under the NIP (as a free or subsidised option) and in the private market. Check with your local health centre or the Vaccine Panda catalogue for pricing.

Want to explore all available vaccines for your family? View Full Vaccine Catalogue and see how the CRI Kasauli Td fits into your child’s overall immunisation plan.

By choosing the CRI Kasauli Td vaccine and leveraging home vaccination services, Delhi families can ensure timely protection against tetanus and diphtheria while keeping their busy schedules intact.